Trump Signs Halt Fentanyl Act To Strengthen Drug Penalties

In partnership with

Hello! This is July 16, 2025.

Burned out by the news? There’s a better way.

Outrage headlines. Never-ending feeds. Everyone shouting, no one listening.

Keeping up with political news today can feel more like emotional labor than staying informed. That’s why Tangle exists.

Tangle is an independent, nonpartisan newsletter that covers one major political story each day. It breaks down the facts, shows how the left, right, and center are talking about it, and adds clear, honest analysis — without the spin, hysteria, or bias.

No sides to pick. Just clear, honest analysis from an independent source — all in under 10 minutes a day.

More than 400,000 readers — no matter their politics — trust Tangle to get the full picture and stay informed without getting burnt out.

If you’re tired of feeling overwhelmed by the news — but still want to understand what’s really happening — give Tangle a try.

 

🦅 Top American News 📰

Trump Signs Halt Fentanyl Act To Strengthen Drug Penalties

President Trump signed the HALT Fentanyl Act, permanently classifying fentanyl analogs as Schedule I to empower law enforcement. He hailed it as a “historic step toward justice” and vowed to crack down on the overdose crisis. The law also tightens research registration rules and shuts down underground production loopholes. Affected families welcomed the move.

 

Sen Cassidy Raises $1.6M, Outpacing Challengers

Senator Bill Cassidy (R‑LA) generated $1.6 million in Q2 fundraising, surpassing opponents in the primary race. He enters the next round with $8.7 million cash on hand, thanks in part to SuperPAC support. Challenger Blake Miguez raised $800K plus a $1M self-loan, while John Fleming holds about $2.1M. The strong showing positions Cassidy solidly heading into the fall election.

 

‘Big Beautiful Bill’ Sparks Midterm Buzz, Says Kraushaar

Fox News analyst Josh Kraushaar told Guy Benson today that the “Big Beautiful Bill” could shape Republican prospects in 2026. The initiative, promoted by VP Vance in Pennsylvania, focuses on manufacturing tax breaks and trade incentives. Kraushaar noted its rollout is being watched as a potential vote-winner for blue-collar voters. Early signs suggest midterm implications are already heating up.

 

💰 Top Financial News 📈

Trump Denies Plans To Fire Fed Chair Powell

President Trump dismissed reports of plans to remove Federal Reserve Chair Jerome Powell, stating, “We’re not planning on doing anything.” He admitted the topic came up in discussions with GOP lawmakers, but emphasized no action is planned. Markets remain alert as rate cut debates continue amid fiscal uncertainty.

 

Five High‑Yield Stocks Under $10 Shine Ahead Of Rate Cuts

247WallSt highlights five ultra‑high‑yield stocks trading under $10 that could benefit if the Fed cuts rates. Analysts say interest rate reductions could provide a strong tailwind for these overlooked income plays. With attractive yields and low prices, now may be a strategic entry point. Income-focused investors may want to take notice.

 

💊 Top Health News 💪

Flavonoid‑Rich Diet Linked To Lower Disease Risk

A 10‑year study of 120,000 adults found that diets rich in flavonoids—found in berries, tomatoes, dark chocolate, and more—reduce the risk of heart disease, Type 2 diabetes, respiratory illness by ≈10%, and overall mortality by 16%. Researchers recommend a varied plant-heavy intake to maximize benefits. The findings reinforce that everyday foods can yield serious health rewards.

 

‘Magic Mushroom’ Compound Extends Lifespan In Mice

New research shows psilocybin—the psychoactive compound in magic mushrooms—extended lifespan and reversed aging signs in aged mice. Scientists say it could hint at anti‑aging potential if validated in humans. Though preliminary, the results feed growing interest in psychedelics for therapeutic use. Experts caution that much more research is needed.

 

📖 Today’s Words Of Wisdom

“Liberty means responsibility. That is why most men dread it.”

George Bernard Shaw